Kiniksa Insider Sells $309K Worth of Shares Amid 120% Stock Surge
Michael R Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals (KNSA), sold 6,625 shares worth $309,321 in an open-market transaction on April 9, 2026, as reported by an SEC Form 4 filing. The sale was part of a pre-arranged 10b5-1 trading plan and did not indicate a full exit from the company. Kiniksa's stock has surged 120% over the past year.
Tickers: $KNSA
Topics: executive transactions insider trading SEC filings stock price movement